Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Amphastar Pharmaceuticals Company Profile (NASDAQ:AMPH)

Consensus Ratings for Amphastar Pharmaceuticals (NASDAQ:AMPH) (?)
Ratings Breakdown: 4 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $18.00 (21.70% upside)

Analysts' Ratings History for Amphastar Pharmaceuticals (NASDAQ:AMPH)
Show:
DateFirmActionRatingPrice TargetActions
5/15/2015BMO Capital MarketsReiterated RatingOutperform$19.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/14/2015Jefferies GroupSet Price TargetBuy$18.00 -> $19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/25/2015Jefferies GroupBoost Price TargetBuy$15.00 -> $18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/13/2014Jefferies GroupBoost Price TargetBuy$14.00 -> $15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/6/2014BMO Capital MarketsBoost Price Target$17.00 -> $18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/21/2014Needham & Company LLCInitiated CoverageBuy$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/21/2014Piper JaffrayInitiated CoverageOverweight$16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/21/2014BMO Capital MarketsInitiated CoverageOutperform$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/21/2014Jefferies GroupInitiated CoverageBuy$14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/26/2013 forward)